Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Cell Death Differ ; 19(3): 461-9, 2012 Mar.
Article in English | MEDLINE | ID: mdl-21869831

ABSTRACT

Notch signaling is involved in several cell lineage determination processes during embryonic development. Recently, we have shown that Sox9 is most likely a primary target gene of Notch1 signaling in embryonic stem cells (ESCs). By using our in vitro differentiation protocol for chondrogenesis from ESCs through embryoid bodies (EBs) together with our tamoxifen-inducible system to activate Notch1, we analyzed the function of Notch signaling and its induction of Sox9 during EB differentiation towards the chondrogenic lineage. Temporary activation of Notch1 during early stages of EB, when lineage determination occurs, was accompanied by rapid and transient Sox9 upregulation and resulted in induction of chondrogenic differentiation during later stages of EB cultivation. Using siRNA targeting Sox9, we knocked down and adjusted this early Notch1-induced Sox9 expression peak to non-induced levels, which led to reversion of Notch1-induced chondrogenic differentiation. In contrast, continuous Notch1 activation during EB cultivation resulted in complete inhibition of chondrogenic differentiation. Furthermore, a reduction and delay of cardiac differentiation observed in EBs after early Notch1 activation was not reversed by siRNA-mediated Sox9 knockdown. Our data indicate that Notch1 signaling has an important role during early stages of chondrogenic lineage determination by regulation of Sox9 expression.


Subject(s)
Cell Differentiation/physiology , Chondrogenesis/physiology , Embryonic Stem Cells/metabolism , Receptor, Notch1/metabolism , SOX9 Transcription Factor/metabolism , Signal Transduction/physiology , Animals , Cell Differentiation/drug effects , Cell Line , Chondrogenesis/drug effects , Embryonic Stem Cells/cytology , Estrogen Antagonists/pharmacology , Gene Knockdown Techniques , Humans , Mice , Receptor, Notch1/genetics , SOX9 Transcription Factor/genetics , Signal Transduction/drug effects , Tamoxifen/pharmacology
6.
Cell Death Differ ; 15(2): 398-407, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18049480

ABSTRACT

Signaling mediated by activation of the transmembrane receptor Notch influences cell-fate decisions, differentiation, proliferation, and cell survival. Activated Notch reduces proliferation by altering cell-cycle kinetics and promotes differentiation in hematopoietic progenitor cells. Here, we investigated if the G(1) arrest and differentiation induced by activated mNotch1 are dependent on tumor suppressor p53, a critical mediator of cellular growth arrest. Multipotent wild-type p53-expressing (p53(wt)) and p53-deficient (p53(null)) hematopoietic progenitor cell lines (FDCP-mix) carrying an inducible mNotch1 system were used to investigate the effects of proliferation and differentiation upon mNotch1 signaling. While activated Notch reduced proliferation of p53(wt)-cells, no change was observed in p53(null)-cells. Activated Notch upregulated the p53 target p21(cip/waf) in p53(wt)-cells, but not in p53(null)-cells. Induction of the p21(cip/waf) gene by activated Notch was mediated by increased binding of p53 to p53-binding sites in the p21(cip/waf) promoter and was independent of the canonical RBP-J binding site. Re-expression of p53(wt) in p53(null) cells restored the inhibition of proliferation by activated Notch. Thus, activated Notch inhibits proliferation of multipotent hematopoietic progenitor cells via a p53-dependent pathway. In contrast, myeloid and erythroid differentiation was similarly induced in p53(wt) and p53(null) cells. These data suggest that Notch signaling triggers two distinct pathways, a p53-dependent one leading to a block in proliferation and a p53-independent one promoting differentiation.


Subject(s)
Erythropoiesis , Hematopoietic Stem Cells/physiology , Multipotent Stem Cells/physiology , Myelopoiesis , Receptor, Notch1/metabolism , Tumor Suppressor Protein p53/metabolism , Animals , Cell Proliferation , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/metabolism , Mice , Mice, Mutant Strains , Multipotent Stem Cells/cytology , Multipotent Stem Cells/metabolism , Signal Transduction
7.
J Biol Chem ; 276(28): 26012-21, 2001 Jul 13.
Article in English | MEDLINE | ID: mdl-11335713

ABSTRACT

The high mobility group (HMG) proteins of the AT-hook family (HMGA) lie downstream in regulatory networks with protein kinase C, Cdc2 kinase, MAP kinase, and casein kinase 2 (CK2) as final effectors. In the cells of the midge Chironomus, almost all of the HMGA protein (cHMGA) is phosphorylated by CK2 at two adjacent sites. 40% of the protein population is additionally modified by MAP kinase. Using spectroscopic and protein footprinting techniques, we analyzed how individual and consecutive steps of phosphorylation change the conformation of an HMGA protein and affect its contacts with poly(dA-dT).poly(dA-dT) and a fragment of the interferon-beta promoter. We demonstrate that phosphorylation of cHMGA by CK2 alters its conformation and modulates its DNA binding properties such that a subsequent phosphorylation by Cdc2 kinase changes the organization of the protein-DNA complex. In contrast, consecutive phosphorylation by MAP kinase, which results in a dramatic change in cHMGA conformation, has no direct effect on the complex. Because the phosphorylation of the HMGA proteins attenuates binding affinity and reduces the extent of contacts between the DNA and protein, it is likely that this process mirrors the dynamics and diversity of regulatory processes in chromatin.


Subject(s)
Chironomidae/metabolism , High Mobility Group Proteins/metabolism , Animals , Chironomidae/genetics , DNA/genetics , DNA/metabolism , High Mobility Group Proteins/genetics , Phosphorylation , Protein Binding , Protein Conformation
8.
J Biol Chem ; 276(3): 1984-92, 2001 Jan 19.
Article in English | MEDLINE | ID: mdl-11034995

ABSTRACT

High mobility group (HMG) proteins HMGI, HMGY, HMGI-C, and Chironomus HMGI are DNA-binding proteins thought to modulate the assembly and the function of transcriptional complexes. Each of these proteins contains three DNA-binding domains (DBD), properties of which appear to be regulated by phosphorylation. High levels of these proteins are characteristic for rapidly dividing cells in embryonic tissues and tumors. On the basis of their occurrence, specific functions for each of these proteins have been postulated. In this study we demonstrate differences in the nature of contacts of these proteins with promoter region of the interferon-beta gene. We show that HMGI and HMGY interact with this DNA via three DBDs, whereas HMGI-C and Chironomus HMGI bind to this DNA using only two domains. Phosphorylation of HMGY protein by Cdc2 kinase leads to impairing of contacts between the N-terminally located DBD and a single promoter element. The perturbations in the architecture of the protein.DNA complexes involve changes in the degree of unbending of the intrinsically bent IFNbeta promoter. Our results provide first insights into the molecular basis of functional specificity of proteins of the HMGI/Y family and their regulation by phosphorylation.


Subject(s)
DNA-Binding Proteins/metabolism , DNA/metabolism , High Mobility Group Proteins/metabolism , Mitosis , Transcription Factors/metabolism , DNA/chemistry , HMGA1a Protein , Interferon-beta/genetics , Phosphorylation , Promoter Regions, Genetic , Protein Binding , Recombinant Proteins/metabolism
9.
Biochemistry ; 39(47): 14419-25, 2000 Nov 28.
Article in English | MEDLINE | ID: mdl-11087394

ABSTRACT

High-mobility group I/Y (HMGI/Y) proteins are chromosomal proteins involved in gene and chromatin regulation. Elevated levels of HMGI/Y proteins were reported in diverse malignant tumors, and rearrangements of their genes are casually involved in the development of benign tumors. In humans, the chromosomal locus Xp22 has been often found to be affected in diverse benign mesenchymal tumors. Recent studies revealed that this region contains a retropseudogene HMGIYL1 which potentially can be activated in a way of "exonization" upon aberrations involving this region. The coding sequence of the HMGIY-L1 is highly homologous to the HMGI(Y) gene. On the protein level, both HMGIYL1 and HMGI differ at few amino acid residues, including their putative DNA-binding domains (DBDs). Here we have approached the question of whether the HMGIYL1 product would be able to adopt a role of HMGI in the context of binding to gene promoters and chromatin. Comparative binding studies, employing protein footprinting technique, revealed that HMGIYL1 has lost the ability to bind to the promoter of the interferon beta gene, but retained its high affinity for the four-way junction DNA. Our results stress the importance of particular residues within the DBDs for DNA binding and demonstrate that tight binding of HMGI/Y proteins to the four-way junction DNA can be achieved in alternative ways. The binding of HMGIYL1 to four-way junction DNA suggests that activation of the HMGIYL1 gene would yield a protein sharing some binding properties with HMG1-box proteins and histone H1. Thus, the HMGIYL1 could interplay together with these components in chromatin regulation.


Subject(s)
DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , High Mobility Group Proteins/genetics , High Mobility Group Proteins/metabolism , Point Mutation , Promoter Regions, Genetic , Active Transport, Cell Nucleus/genetics , Adenine/metabolism , Amino Acid Sequence , Animals , Caenorhabditis elegans/genetics , Cell Nucleus/genetics , Cell Nucleus/metabolism , Chromosomes, Human/genetics , Chromosomes, Human/metabolism , Genetic Vectors/genetics , Green Fluorescent Proteins , Humans , Interferon-beta/genetics , Interferon-beta/metabolism , Luminescent Proteins/genetics , Molecular Sequence Data , Nucleic Acid Conformation , Phosphoproteins/metabolism , Phosphorylation , Protein Footprinting , Protein Structure, Tertiary/genetics , Pseudogenes , Sequence Homology, Amino Acid , Thymine/metabolism
10.
Int J Mol Med ; 6(4): 409-19, 2000 Oct.
Article in English | MEDLINE | ID: mdl-10998430

ABSTRACT

The family of chromosomal high mobility group I/Y consists of proteins involved in gene regulation and chromatin organization. A common feature of these proteins is the presence of multiple copies of DNA binding domains (DBD), the so-called AT-hooks. Bi- or tridendate interaction of two or three DBDs with appropriately spaced AT-rich DNA tracts forms the basis of binding specificity of the HMGI/Y proteins. Binding of HMGI/Y to structure-specific targets within the minor groove affects the DNA conformation and facilitates binding of transcription factors. Phosphorylation by casein kinase 2, Cdc2, and other kinases attenuates the DNA-binding affinity of HMGI/Y and the extent of perturbation in DNA structure induced by HMGI/Y-binding. In the human genome, two genes coding for HMGI/Y proteins, HMGI(Y) and HMGI-C, have been found. Both are abundantly transcribed in early embryonic and undifferentiated cells. An over-expression of the HMGI/Y proteins is characteristic for malignant tumors, suggesting a relation between high titers of the proteins and neoplastic phenotype. Defects in the HMGI-C gene have been found in a variety of benign tumors, such as uterine leiomyomas, endometrial polyps, lipomas, and pulmonary chondroid hamartomas.


Subject(s)
High Mobility Group Proteins/metabolism , Transcription Factors/metabolism , Amino Acid Sequence , Animals , Cell Transformation, Neoplastic/metabolism , Cell Transformation, Neoplastic/pathology , DNA-Binding Proteins/metabolism , Disease Progression , HMGA1a Protein , High Mobility Group Proteins/genetics , Humans , Molecular Sequence Data , Neoplasms/metabolism , Neoplasms/pathology , Phosphorylation , Sequence Homology, Amino Acid , Transcription Factors/genetics
11.
J Biol Chem ; 275(3): 1793-801, 2000 Jan 21.
Article in English | MEDLINE | ID: mdl-10636877

ABSTRACT

The high mobility group I-C (HMGI-C) protein is an abundant component of rapidly proliferating undifferentiated cells. High level expression of this protein is characteristic for early embryonic tissue and diverse tumors. HMGI-C can function as an architectural factor enhancing the activity of transcription factor NF-kappaB on the beta-interferon promoter. The protein has three minor groove DNA-binding domains (AT-hooks). Here, we describe the complex of HMGI-C with a fragment of the beta-interferon promoter. We show that the protein binds to NRDI and PRDII elements of the promoter with its first and second AT-hook, respectively. Phosphorylation by Cdc2 kinase leads to a partial derailing of the AT-hooks from the minor groove, affecting mainly the second binding domain. In contrast, binding to long AT stretches of DNA involves contacts with all three AT-hooks and is marginally sensitive to phosphorylation. Our data stress the importance of conformation of the DNA binding site and protein phosphorylation for its function.


Subject(s)
CDC2 Protein Kinase/metabolism , DNA/metabolism , High Mobility Group Proteins/metabolism , Amino Acid Sequence , Animals , Base Sequence , CDC2 Protein Kinase/chemistry , DNA Footprinting , Dose-Response Relationship, Drug , HMGA2 Protein , High Mobility Group Proteins/chemistry , High Mobility Group Proteins/genetics , Interferon-beta/genetics , Interferon-beta/metabolism , Methylation , Mice , Models, Genetic , Molecular Sequence Data , Phosphorylation , Promoter Regions, Genetic , Protein Binding , Protein Conformation
12.
J Biol Chem ; 274(29): 20116-22, 1999 Jul 16.
Article in English | MEDLINE | ID: mdl-10400623

ABSTRACT

The high mobility group (HMG) 1 and 2 proteins are the most abundant non-histone components of chromosomes. Here, we report that essentially the entire pool of HMG1 proteins in Drosophila embryos and Chironomus cultured cells is phosphorylated at multiple serine residues located within acidic tails of these proteins. The phosphorylation sites match the consensus phosphorylation site of casein kinase II. Electrospray ionization mass spectroscopic analyses revealed that Drosophila HMGD and Chironomus HMG1a and HMG1b are double-phosphorylated and that Drosophila HMGZ is triple-phosphorylated. The importance of this post-translational modification was studied by comparing some properties of the native and in vitro dephosphorylated proteins. It was found that dephosphorylation affects the conformation of the proteins and decreases their conformational and metabolic stability. Moreover, it weakens binding of the proteins to four-way junction DNA by 2 orders of magnitude, whereas the strength of binding to linear DNA remains unchanged. Based on these observations, we propose that the detected phosphorylation is important for the proper function and turnover rates of these proteins. As the occurrence of acidic tails containing canonical casein kinase II phosphorylation sites is common to diverse HMG and other chromosomal proteins, our results are probably of general significance.


Subject(s)
DNA-Binding Proteins/metabolism , DNA/metabolism , High Mobility Group Proteins/metabolism , Protein Serine-Threonine Kinases/metabolism , Amino Acid Sequence , Animals , Casein Kinase II , Drosophila/enzymology , Endopeptidases/metabolism , High Mobility Group Proteins/chemistry , Humans , Hydrogen-Ion Concentration , Mass Spectrometry , Molecular Sequence Data , Phosphorylation , Protein Processing, Post-Translational , Sequence Homology, Amino Acid , Spectrometry, Fluorescence
13.
J Biol Chem ; 273(32): 20015-20, 1998 Aug 07.
Article in English | MEDLINE | ID: mdl-9685339

ABSTRACT

The high mobility group proteins I and Y (HMGI/Y) are abundant components of chromatin. They are thought to derepress chromatin, affect the assembly and activity of the transcriptional machinery, and associate with constitutive heterochromatin during mitosis. HMGI/Y protein molecules contain three potential DNA-binding motifs (AT-hooks), but the extent of contacts between DNA and the entire protein has not been determined. We have used a protein-footprinting procedure to map regions of the Chironomus HMGI protein molecule that are involved in contacts with DNA. We find that in the presence of double-stranded DNA all AT-hook motifs are protected against hydroxyl radical proteolysis. In contrast, only two motifs were protected in the presence of four-way junction DNA. Large regions that flank the AT-hook motifs were found to be strongly protected against proteolysis in complexes with interferon-beta promoter DNA, suggesting amino acid residues outside the AT-hooks considerably contribute to DNA binding.


Subject(s)
Chironomidae/chemistry , DNA-Binding Proteins/chemistry , DNA/metabolism , High Mobility Group Proteins/chemistry , Nucleic Acid Conformation , Transcription Factors/chemistry , Animals , Binding Sites/physiology , Electrophoresis, Polyacrylamide Gel , Endopeptidases/metabolism , HMGA1a Protein , Humans , Hydroxyl Radical/metabolism , Insect Proteins/chemistry , Interferon-beta/genetics , Oligodeoxyribonucleotides/metabolism , Promoter Regions, Genetic/genetics , Recombinant Proteins/chemistry
14.
J Biol Chem ; 272(43): 27476-83, 1997 Oct 24.
Article in English | MEDLINE | ID: mdl-9341202

ABSTRACT

Cells of the dipteran insect Chironomus contain a high mobility group protein that is homologous to the mammalian high mobility group proteins I/Y (HMGI/Y). These proteins facilitate the assembly of higher order nucleoprotein complexes. In proliferating cells, >30% of Chironomus HMGI was found to be phosphorylated. The phosphorylation sites were mapped to Ser3, Ser22, and Ser72 and were found to be substrates for the kinases Cdc2 (and mitogen-activated protein (MAP)), MAP, and Ca2+/phospholipid-dependent protein kinase, respectively. In mitotically arrested cells, the extent of phosphorylation at Ser3 increased, whereas phosphorylation at Ser22 remained unchanged. In nondividing cells, phosphorylation at Ser3 and Ser22 was strongly reduced. The DNA binding affinity of Chironomus HMGI was not influenced by single phosphorylation at Ser3 or Ser22. In contrast, phosphorylation at both of these sites resulted in a 10-fold weakening of the binding activity and altered the mode of protein-DNA interaction. Since both human and murine HMGI/Y proteins, similarly to the insect HMGI protein, possess phosphorylation sites for Cdc2 and MAP kinases that intersperse the AT-hook DNA-binding motifs, our results may reflect a general mechanism that regulates the properties and function of this class of putative transcriptional regulators.


Subject(s)
CDC2 Protein Kinase/metabolism , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Chironomidae/metabolism , DNA-Binding Proteins/metabolism , High Mobility Group Proteins/metabolism , Transcription, Genetic , Amino Acid Sequence , Animals , Cell Cycle , Cell Division , Cell Line , HMGA1a Protein , High Mobility Group Proteins/chemistry , High Mobility Group Proteins/isolation & purification , Humans , Kinetics , Mammals , Mitosis , Molecular Sequence Data , Peptide Fragments/chemistry , Peptide Fragments/isolation & purification , Phosphopeptides/chemistry , Phosphopeptides/isolation & purification , Phosphorylation , Phosphoserine/analysis , Substrate Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...